Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation

Bone Marrow Transplant. 2018 Mar;53(3):361-365. doi: 10.1038/s41409-017-0053-9. Epub 2017 Dec 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Antilymphocyte Serum / therapeutic use*
  • Cyclophosphamide / therapeutic use*
  • Female
  • Graft vs Host Disease / prevention & control*
  • Hematologic Neoplasms / complications
  • Hematologic Neoplasms / therapy
  • Historically Controlled Study
  • Humans
  • Male
  • Middle Aged
  • Retrospective Studies
  • Unrelated Donors

Substances

  • Antilymphocyte Serum
  • Cyclophosphamide